New Jersey S 2652: Expands entities that may acquire opioid antidotes; creates program within DOH and formalizes reporting requirements.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: S 2652

Sponsors: Gopal, Vin

View New Jersey S 2652 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.